Twist Bioscience: Fiscal Q4 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Twist Bioscience Corp. (TWST) on Friday reported a loss of $46.2 million in its fiscal fourth quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of 81 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 94 cents per share.

The maker of synthetic DNA for the biotechnology industry posted revenue of $66.9 million in the period, also surpassing Street forecasts. Four analysts surveyed by Zacks expected $63.4 million.

For the year, the company reported a loss of $204.6 million, or $3.60 per share. Revenue was reported as $245.1 million.

For the current quarter ending in December, Twist Bioscience said it expects revenue in the range of $67 million to $68 million.

The company expects full-year revenue in the range of $285 million to $290 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on TWST at https://www.zacks.com/ap/TWST